查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085103

生物安全櫃市場：按等級、類型、形式、應用、最終用戶和銷售管道分類－2026-2032年全球市場預測

Biological Safety Cabinet Market by Class, Type, Form, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物安全櫃市場規模將成長至 9.6632 億美元，複合年成長率為 8.87%。

主要市場統計數據
基準年 2025 5.3287億美元
預計年份：2026年 5.7468億美元
預測年份 2032 9.6632億美元
複合年成長率 (%) 8.87%

生物安全櫃市場的發展動力源自於實驗室處理傳染性病原體、人檢體、細胞培養物和無菌材料時，保護工作人員、產品和環境這一不可或缺的要求。 II級生物安全櫃的需求量最高，原因在於其透過可控的向內氣流、垂直層流向下氣流和高效空氣微粒過濾器（HEPA）排氣，實現了對工作人員、產品和環境的全面保護。

世界衛生組織《實驗室生物安全手冊》、美國疾病管制與預防中心/國立衛生研究院《微生物與生物醫學實驗室生物安全》、NSF/ANSI 49 和 EN 12469 中概述的檢驗指南持續影響著採購、認證和維護實務。隨著生物製藥研發、臨床診斷、疫苗生產、公共衛生監測和學術生命科學領域的擴展，生物安全櫃正日益成為重要的實驗室設施，而不僅僅是實驗室家具。

生物安全櫃領域的變革性變化

目前，實驗室的防護設備正從獨立的封閉式裝置轉向互聯互通、符合規範的實驗室生態系統。採購者優先考慮節能型氣流系統、符合人體工學的設計、低噪音運行、非接觸式操作、紫外線循環控制以及可追溯的認證記錄。此外，實驗室也正在更換老舊的防護櫃，以滿足最新的風險評估、永續性目標和審核要求。

人工智慧對生物安全櫃的累積影響

人工智慧 (AI) 正透過預測性維護、氣流異常檢測、數位化服務調度和更智慧的能源最佳化，開始影響生物安全櫃的價值鏈。 AI 模型可以分析感測器數據、小包性能、門扇位置、過濾器堵塞情況、振動模式和警報歷史記錄，從而在性能下降的早期徵兆演變為違規或安全故障之前，及時發現並解決這些問題。

關於生物安全櫃的關鍵區域見解

亞太地區是生物安全櫃市場最具活力的地區之一。這主要得益於中國、印度、日本、韓國、澳洲和東南亞國協不斷擴大的藥品生產、合約研究、疫苗生產能力、醫院診斷以及政府主導的生命科學投資。該地區的成長也歸功於新建和改造實驗室，因為各機構都在遵守國際公認的生物安全和污染控制規範。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

東協地區的需求正受到醫療保健現代化、區域製藥業發展、臨床診斷擴張以及全球實驗室品管標準合規性提升等因素的影響。在海灣合作理事會（GCC）國家，生物安全櫃的普及應用正受益於醫院擴建、國家級研究舉措、生物醫學基礎設施投資以及優先採購經認證且有售後服務支持的設備的集中採購模式。在歐盟，標準仍然是一個重要因素，CE認證、EN 12469性能要求、歐盟GMP標準以及永續性目標都會影響產品選擇和更換的決策。

主要國家引進生物安全櫃的趨勢

在美國，需求主要由美國國立衛生研究院 (NIH) 資助的研究、符合美國疾病管制與預防中心 (CDC) 標準的生物安全規範、生物製藥生產、公共衛生緊急準備以及需要定期認證的大規模部署基地所驅動。在加拿大，公共衛生、學術研究、醫院檢查室和醫學檢查室的安全是重中之重；而在墨西哥，診斷、製藥生產和檢查室現代化是推動發展的主要動力。巴西擁有拉丁美洲最大的市場機遇，其生物醫學研究、疫苗生產、標準檢查室和不斷擴展的臨床檢測網路都佔據重要地位。

為生物安全櫃產業的領導者提供的實用建議

供應商之間的競爭不應僅限於價格，還應體現在認證性能、服務可靠性和生命週期價值等方面。製造商和經銷商可以透過提供符合 NSF/ANSI 49、EN 12469 和相關本地認證標準的機櫃，以及提供快速的現場服務、完善的維護記錄、經過驗證的替換零件和操作人員培訓支持，檢驗市場地位。

生物安全櫃調查調查方法

本調查方法基於系統性方法，結合了二手資料研究、標準審查、法規分析和市場三角驗證。主要參考標準包括世界衛生組織生物安全指南、美國疾病管制與預防中心/美國國立衛生研究院生物醫學實驗室指南建議、美國國家科學基金會/美國國家標準協會49號標準、EN 12469標準、ISO潔淨室和品質框架、歐盟GMP要求以及公開的政府和機構檢查室安全相關資料。

生物安全櫃市場前景的結論

隨著生物安全、污染控制和運作彈性三者日益融合，生物安全櫃正成為現代實驗室基礎設施中不可或缺的設備。其最大的發展機會體現在以下幾個方面：二級生物安全櫃的部署、老舊設備的更換、生物製藥和診斷能力的拓展，以及對經過認證和維護的設備日益成長的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物安全櫃市場：依類別分類

  • 一級
  • 二類
  • 三級

第8章：生物安全櫃市場：按類型分類

  • 橫版
  • 垂直

第9章：生物安全櫃市場：依形式分類

  • 工作檯面
  • 固定式
  • 移動的

第10章：生物安全櫃市場：依應用領域分類

  • 細胞培養
  • 診斷
  • 微生物學
  • 藥物測試

第11章：生物安全櫃市場：依最終用戶分類

  • 學術研究機構
  • 醫院和臨床檢查室
  • 製藥和生物技術公司

第12章：生物安全櫃市場：依銷售管道分類

  • 離線
  • 線上

第13章：生質安全櫃市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：生物安全櫃市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：生物安全櫃市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Air Science USA LLC
  • AirClean Systems, Inc.
  • AIRTECH Japan Ltd.
  • Berner International GmbH
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Biolab Scientific Srl
  • CHC Biotech Co., Ltd.
  • Cruma SA
  • Esco Micro Pte. Ltd.
  • EuroClone SpA
  • Faithful Instrument（Hebei）Co.,Ltd.
  • FASTER Srl
  • Germfree Laboratories, Inc.
  • Getinge AB
  • Haier Biomedical
  • Heal Force Bio-Meditech Holdings Limited
  • Kewaunee International Group
  • Labconco Corporation
  • LAMSYSTEMS CC
  • Mystaire Inc.
  • NuAire, Inc.
  • Shellab, Inc.
  • Suzhou Antai Airtech Co., Ltd.
  • Telstar, SL
  • Thermo Fisher Scientific Inc.
  • Yamato Scientific Co., Ltd.
Product Code: MRR-437D4595793A

The Biological Safety Cabinet Market is projected to grow by USD 966.32 million at a CAGR of 8.87% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 532.87 million
Estimated Year [2026] USD 574.68 million
Forecast Year [2032] USD 966.32 million
CAGR (%) 8.87%

The biological safety cabinet market is anchored in a non-negotiable requirement: protecting personnel, products, and the environment when laboratories handle infectious agents, human specimens, cell cultures, and sterile materials. Demand is strongest for Class II biosafety cabinets because they combine personnel, product, and environmental protection through controlled inward airflow, vertical laminar downflow, and HEPA-filtered exhaust.

Verified guidance from the WHO Laboratory Biosafety Manual, the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, NSF/ANSI 49, and EN 12469 continues to shape procurement, certification, and maintenance practices. As biopharmaceutical R&D, clinical diagnostics, vaccine production, public health surveillance, and academic life sciences expand, biological safety cabinets are increasingly treated as critical containment infrastructure rather than commodity laboratory furniture.

Transformative Shifts in the Biological Safety Cabinet Landscape

The landscape is shifting from standalone containment equipment toward connected, compliance-ready laboratory ecosystems. Buyers are prioritizing energy-efficient airflow systems, ergonomic designs, low-noise operation, touchless controls, ultraviolet cycle management, and documented certification histories. Laboratories are also replacing aging cabinets to meet updated risk assessments, sustainability targets, and audit expectations.

Another major shift is the convergence of biosafety and aseptic processing. Pharmaceutical, biotechnology, cell therapy, and clinical laboratory users require cabinets that support both containment and contamination control. This is accelerating demand for validated airflow performance, reliable HEPA filtration, traceable service records, and compatibility with broader quality systems used in GLP, GMP, and ISO-aligned environments.

Cumulative Impact of Artificial Intelligence on Biosafety Cabinets

Artificial intelligence is beginning to influence the biological safety cabinet value chain through predictive maintenance, airflow anomaly detection, digital service scheduling, and smarter energy optimization. AI models can analyze sensor data, motor performance, sash position, filter loading, vibration patterns, and alarm histories to identify early signs of performance drift before they become compliance or safety failures.

The cumulative impact is operational rather than purely technical. AI-enabled monitoring can reduce unplanned downtime, support evidence-based maintenance, improve asset utilization, and strengthen audit readiness, especially in high-throughput diagnostics and biomanufacturing facilities. However, AI does not replace accredited field certification under recognized standards such as NSF/ANSI 49 or EN 12469; it strengthens the decision-making layer around validated containment performance.

Key Regional Insights for Biological Safety Cabinets

Asia-Pacific is one of the most dynamic regions for biological safety cabinets, supported by expanding pharmaceutical production, contract research, vaccine capacity, hospital diagnostics, and government-backed life sciences investment across China, India, Japan, South Korea, Australia, and ASEAN economies. The region's growth is tied to both new laboratory construction and replacement demand as institutions standardize around internationally recognized biosafety and contamination-control practices.

North America remains a high-value region due to extensive academic research networks, public health laboratories, biopharmaceutical manufacturing, and strict certification practices, with annual field testing and documentation often embedded in institutional safety programs. Europe benefits from strong regulatory alignment around EN 12469, EU GMP expectations, CE conformity, and mature laboratory infrastructure. Latin America is led by Brazil and Mexico as public health, pharmaceutical, and clinical diagnostic capabilities develop. The Middle East, particularly GCC countries, is investing in healthcare infrastructure, medical research, and laboratory modernization, while Africa's demand is supported by infectious disease surveillance, reference laboratory expansion, antimicrobial resistance monitoring, and international health security programs.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is shaped by healthcare modernization, regional pharmaceutical manufacturing, clinical diagnostics expansion, and increasing alignment with global laboratory quality practices. GCC countries are adopting biological safety cabinets through hospital expansion, national research initiatives, biomedical infrastructure investment, and centralized procurement models that favor certified, service-supported equipment. The European Union remains highly standards-driven, with CE conformity, EN 12469 performance expectations, EU GMP practices, and sustainability goals influencing product selection and replacement decisions.

BRICS markets combine strong demand potential with growing domestic manufacturing ambitions, especially in China, India, and Brazil, where biologics, vaccines, diagnostics, and public health laboratories are expanding. G7 countries represent the most mature replacement and premium-technology environments, where buyers prioritize lifecycle cost, certification records, energy efficiency, ergonomic design, and digital monitoring. NATO member states also place strategic emphasis on biosecurity, medical readiness, dual-use research oversight, and resilient public health laboratories, reinforcing demand for dependable laboratory containment equipment.

Key Country Insights for Biological Safety Cabinet Adoption

The United States leads demand through NIH-funded research, CDC-aligned biosafety practices, biopharmaceutical manufacturing, public health preparedness, and a large installed base requiring routine certification. Canada emphasizes public health, academic research, hospital laboratories, and healthcare laboratory safety, while Mexico is advancing diagnostics, pharmaceutical production, and laboratory modernization. Brazil is Latin America's largest opportunity due to biomedical research, vaccine production, reference laboratories, and expanding clinical laboratory networks.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature demand driven by life sciences research, hospital diagnostics, academic institutes, and pharmaceutical quality systems, while Russia faces procurement complexity linked to localization requirements and trade constraints. China and India are major growth engines due to large-scale R&D, biologics, vaccine, biosimilar, and diagnostics capacity. Japan, South Korea, and Australia favor high-quality, standards-compliant cabinets for advanced research, clinical testing, infectious disease preparedness, and regulated manufacturing environments.

Actionable Recommendations for Biological Safety Cabinet Leaders

Vendors should compete on certified performance, service reliability, and lifecycle value rather than price alone. Manufacturers and distributors can strengthen positioning by offering cabinets aligned with NSF/ANSI 49, EN 12469, and relevant local certification practices, while providing fast field service, documented maintenance, validated replacement parts, and operator training support.

Strategic priorities include expanding regional service networks, integrating IoT and AI-enabled monitoring without compromising certification integrity, improving energy efficiency, and designing cabinets for ergonomic use in high-throughput laboratories. Vendors should also support procurement teams with total cost of ownership data, sustainability documentation, airflow and filter performance evidence, and clear guidance on cabinet selection by biosafety level, workflow, and application risk.

Research Methodology for the Biological Safety Cabinet Study

The research methodology is based on a structured approach combining secondary research, standards review, regulatory analysis, and market triangulation. Core reference points include WHO biosafety guidance, CDC/NIH BMBL recommendations, NSF/ANSI 49, EN 12469, ISO cleanroom and quality frameworks, EU GMP expectations, and publicly available government and institutional laboratory safety resources.

Market interpretation is further supported by analysis of public disclosures, product portfolios, certification practices, procurement patterns, public health infrastructure investments, and regional life sciences activity. Insights are validated through cross-comparison of technical standards, end-user requirements, and observable adoption trends across pharmaceutical, biotechnology, diagnostics, academic, healthcare, and government laboratory settings.

Conclusion on the Biological Safety Cabinet Market Outlook

Biological safety cabinets are becoming indispensable assets in modern laboratory infrastructure as biosafety, contamination control, and operational resilience converge. The strongest opportunities are linked to Class II cabinet adoption, replacement of aging installed bases, growth in biopharmaceutical and diagnostic capacity, and rising demand for certified, service-backed equipment.

The market's next phase will be defined by smarter monitoring, energy-efficient engineering, documented compliance, and dependable regional service. Organizations that combine validated containment performance with digital readiness, regulatory alignment, and lifecycle support will be best positioned to capture sustainable growth across mature and emerging laboratory environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biological Safety Cabinet Market, by Class

  • 7.1. Class I
  • 7.2. Class II
  • 7.3. Class III

8. Biological Safety Cabinet Market, by Type

  • 8.1. Horizontal
  • 8.2. Vertical

9. Biological Safety Cabinet Market, by Form

  • 9.1. Benchtop
  • 9.2. Floor-standing
  • 9.3. Mobile

10. Biological Safety Cabinet Market, by Application

  • 10.1. Cell Culture
  • 10.2. Diagnostics
  • 10.3. Microbiology
  • 10.4. Pharmaceutical Testing

11. Biological Safety Cabinet Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Hospitals & Clinical Laboratories
  • 11.3. Pharmaceutical & Biotech Firms

12. Biological Safety Cabinet Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. Biological Safety Cabinet Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Biological Safety Cabinet Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Safety Cabinet Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Air Science USA LLC
  • 17.2. AirClean Systems, Inc.
  • 17.3. AIRTECH Japan Ltd.
  • 17.4. Berner International GmbH
  • 17.5. Biobase Biodusty(Shandong), Co., Ltd.
  • 17.6. Biolab Scientific S.r.l.
  • 17.7. CHC Biotech Co., Ltd.
  • 17.8. Cruma S.A.
  • 17.9. Esco Micro Pte. Ltd.
  • 17.10. EuroClone S.p.A.
  • 17.11. Faithful Instrument (Hebei) Co.,Ltd.
  • 17.12. FASTER S.r.l.
  • 17.13. Germfree Laboratories, Inc.
  • 17.14. Getinge AB
  • 17.15. Haier Biomedical
  • 17.16. Heal Force Bio-Meditech Holdings Limited
  • 17.17. Kewaunee International Group
  • 17.18. Labconco Corporation
  • 17.19. LAMSYSTEMS CC
  • 17.20. Mystaire Inc.
  • 17.21. NuAire, Inc.
  • 17.22. Shellab, Inc.
  • 17.23. Suzhou Antai Airtech Co., Ltd.
  • 17.24. Telstar, S.L.
  • 17.25. Thermo Fisher Scientific Inc.
  • 17.26. Yamato Scientific Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CLASS I MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CLASS I MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CLASS I MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CLASS II MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CLASS II MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CLASS II MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CLASS III MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CLASS III MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CLASS III MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HORIZONTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HORIZONTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HORIZONTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VERTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VERTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VERTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLOOR-STANDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLOOR-STANDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLOOR-STANDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MOBILE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MOBILE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MOBILE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPITALS & CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPITALS & CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPITALS & CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL & BIOTECH FIRMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL & BIOTECH FIRMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL & BIOTECH FIRMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 112. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 114. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 133. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 140. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)